Divis Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2025 ,inter alia, to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2025.

pdf

Divi's Laboratories Ltd.

17 Oct 2025

6804.50

0.01%

SAST

Divis Laboratories Ltd - 532488 - Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India

pdf

Divi's Laboratories Ltd.

17 Oct 2025

6804.50

0.01%

SAST

Divis Laboratories Ltd - 532488 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India

pdf

Divi's Laboratories Ltd.

14 Oct 2025

6804.50

0.01%

Company Update

Divis Laboratories Ltd - 532488 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Clippings-intimation of opening of special window for re-lodgment of transfer requests of physical shares

pdf

Divi's Laboratories Ltd.

13 Oct 2025

6804.50

0.01%

Divis Labs rallies 13% in 1 week; What's driving pharma stock?

Business Standard

Divis stock gained 2% in Monday's intra-day deals. Reports suggest the company is well positioned to benefit from emerging trends across both API and CDMO domains through innovation and capex.

Divi's Laboratories .. has an average target of 6414.33 from 6 brokers.

Divi's Laboratories Ltd.

10 Oct 2025

6804.50

0.01%

Pharma stocks surge as generic drugs may escape Trump tariffs

Business Line

All major pharma stocks advanced, led by Divis Laboratories, which jumped 5.05%, followed by Cipla's 2.87% gain

Divi's Laboratories Ltd. is trading above all available SMAs

Divi's Laboratories Ltd.

07 Oct 2025

6804.50

0.01%

Company Update

Divis Laboratories Ltd - 532488 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Regulation 74(5) of SEBI(DP) Regulations, 2018

pdf

Divi's Laboratories Ltd.

30 Sep 2025

6804.50

0.01%

SAST

Divis Laboratories Ltd - 532488 - Closure of Trading Window

BSE India

Intimation of closure of Trading Window from October 01, 2025 till 48 hours after declaration of unaudited financial results of the Company for the quarter and half year ended September 30, 2025.

pdf